Efficacy and safety of single‐dose anti‐thymocyte globulin versus basiliximab induction therapy in pediatric kidney transplant recipients: A retrospective comparative cohort study.
Saved in:
| Title: | Efficacy and safety of single‐dose anti‐thymocyte globulin versus basiliximab induction therapy in pediatric kidney transplant recipients: A retrospective comparative cohort study. |
|---|---|
| Authors: | Custodio, Luciana de Fatima Porini1,2 (AUTHOR), Martins, Suelen Bianca Stopa1 (AUTHOR), Viana, Laila Almeida1 (AUTHOR), Cristelli, Marina Pontello1 (AUTHOR), Requião‐Moura, Lucio1,2 (AUTHOR), Chow, Charles Yea Zen1 (AUTHOR), Camargo, Suzana Friedlander Del Nero1 (AUTHOR), Nakamura, Monica Rika1 (AUTHOR), Foresto, Renato Demarchi1 (AUTHOR), Tedesco‐Silva, Helio1,2 (AUTHOR) heliotedesco@medfarm.com.br, Medina‐Pestana, Jose1,2 (AUTHOR) |
| Source: | Pediatric Transplantation. May2024, Vol. 28 Issue 3, p1-13. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
